The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient. - The examination of the effects of Teneligliptin on blood glucose and albuminuria in type 2 diabetic patients with nephropathy, whose glycemic control is insufficient.

Kanazawa Medical University0 sites50 target enrollmentDecember 12, 2014

Overview

No summary available.

Registry

who.int

Start Date

December 12, 2014

End Date

September 30, 2017

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\)Patient who have a history of allergy to Teneligliptin. 2\)Patients who have severe ketosis, diabetic coma, diabetic pre\-coma, or type 1 diabetes 3\)Patients who have severe infection, surgery, planned surgery, severe trauma. 4\)Women who are pregnant, or possibility of pregnant, or wish to pregnant, or lactating. 5\)Patients with transit disorder in the digestive tract or peptic ulcer and esophageal varix (this product may irritate affected area.) and patients whom physician judges as inappropriate 6\)Patients with a predisposition to severe and habitual constipation (this product may exacerbate constipation) and patients whom physician judges as inappropriate 7\)Patients who are considered unsuitable for inclusion by the attending physician.